Clinical trial
MK0354 Clinical Efficacy and Tolerability Study (0354-004)
NCT00337415 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00337415 |
|---|---|
| Title | MK0354 Clinical Efficacy and Tolerability Study (0354-004) |
| Official title | Proprietary Information - Exploratory (Non-Confirmatory) Trial |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Dyslipidemia |
| Intervention type | Drug |
| Interventions | MK0354 |
| Enrollment | 65 |
| Start date | May 1, 2006 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Jun 16, 2006 |
| Last update posted | May 18, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: